AXSM Performance: 77.5% Return (12 Months)

AXSM returned 77.5% over 12 months, outperforming the S&P 500 (37.7%). Volatility: 41.0%.

RS IBD 49.33
Top 37% in Peers
Volatility 41.0%
Top 38% in Peers
Total Return 12m 77.54%
Top 39% in Peers
RS Rating 82.70
Top 37% in Peers
P/E
P/E Trailing 0.00
P/E Forward 333
High / Low 52w
52 Week High 189.10 USD
52 Week Low 95.65 USD
Sentiment
VRO Trend Strength ±100 68.64
Buy Signal ±3 0.85
Drawdowns 3y
Max Drawdown 36.45%
Mean Drawdown 13.57%
Compare performance with 81 peers in Pharmaceuticals
12m Total Return: AXSM (77.5%) vs PEER ETF Total Return of Axsome Therapeutics versus broad market ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for AXSM Performance: 77.5% Return (12 Months)

Top Performer in Pharmaceuticals (5/81)

Short Term Performance
SYMBOL 1W 1M 3M
IRD 9.81% 7.97% 157.50%
ELVN 13.60% 44.40% 84.65%
NKTR -0.83% 8.58% 81.18%
ETON 4.08% 58.05% 59.78%
PAHC 7.12% 20.25% 48.02%
AXSM 0.82% 5.29% 3.37%
Long Term Performance
SYMBOL 6M 12M 5Y
RLMD 229.11% 2683.96% -80.35%
TERN 537.53% 2468.78% 196.84%
ANRO 249.60% 969.46% 35.69%
NKTR 32.74% 916.72% -73.20%
BIOA 218.17% 493.42% -1.47%
AXSM 45.89% 77.54% 233.76%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
MRK NYSE
Merck
299B 5.96% 61.7% 98.2% 16.6 23.5 3.68 20.7% -1.27%
GSK NYSE
GlaxoSmithKline
113B 3.35% 74.8% 96.4% 15.5 22.4 0.50 -17.9% -45.1%
IPN PA
Ipsen
15.9B 5.77% 66.5% 130% 31.4 17.7 1.24 -15.1% -46.2%
RPRX NASDAQ
Royalty Pharma
28.1B 4.49% 59.0% 30.6% 27.3 29.8 2.78 -23.5% -44.0%
JNJ NYSE
Johnson & Johnson
586B -0.53% 65.4% 71.9% 22.0 21.1 1.71 12.4% -2.16%
AZN NASDAQ
AstraZeneca
315B 4.78% 60.1% 130% 31.2 19.3 1.65 71.9% 104%
INVA NASDAQ
Innoviva
1.72B 5.82% 36.9% 102% 6.98 11.9 0.34 0.60% -1.26%
PHAT NASDAQ
Phathom Pharmaceuticals
894M 6.30% 178% -68.9% - - - 67.6% 53.3%

Performance: AXSM vs S&P 500

Total Return vs S&P 500
PERIOD AXSM S&P 500
1 Week 0.82% 3.17%
1 Month 5.29% -0.06%
3 Months 3.37% -1.69%
6 Months 45.89% 1.00%
12 Months 77.54% 37.72%
5 Years 233.76% 75.84%

AXSM Performance FAQ

Does AXSM outperform the market?

Yes, AXSM significantly outperforms the market. Over the past 12 months, AXSM returned 77.54% compared to 37.72% for the S&P 500.

What is the AXSM return over the last 12 months?

AXSM has returned 77.54% over the past 12 months, including dividends. Over 3 months the return was 3.37%, and over 5 years 233.76%.

How risky is AXSM?

AXSM has relatively low risk with a maximum drawdown of 36.45% over the past 3 years. The average drawdown is 13.57%.

AXSM vs Sectors (12m)

Sorted by outperformance. Positive = AXSM beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP 66.1%
Health Care XLV 63%
Financials XLF 59.2%
Real Estate XLRE 59.1%
Consumer Discretionary XLY 50.9%
Consumer Discretionary XLY 50.9%
Communication Services XLC 43.8%
Materials XLB 35.5%
Industrials XLI 29.2%
Energy XLE 20.8%
Technology XLK 19%

AXSM vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY 39.8%
Emerging Market EEM 16.9%
Gold GLD 19.6%
Long-Term Bonds TLT 74.7%
Risk-Free Cash SHY 74%